This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sharek, P. J.
Right arrow Articles by Bergman, D. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sharek, P. J.
Right arrow Articles by Bergman, D. A.
Related Collections
Right arrow Nutrition & Metabolism
Right arrow Allergy & Dermatology

PEDIATRICS Vol. 106 No. 1 July 2000, p. e8

ELECTRONIC ARTICLE:
The Effect of Inhaled Steroids on the Linear Growth of Children With Asthma: A Meta-analysis

Received Oct 18, 1999; accepted Feb 16, 2000.

Paul J. Sharek and David A. Bergman

From the Division of General Pediatrics, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California.

Objective.  To determine whether inhaled steroid therapy causes delayed linear growth in children with asthma.

Data Sources.  Medline (1966-1998), Embase (1980-1998), and Cinahl (1982-1998) databases and bibliographies of included studies were searched for randomized, controlled trials of inhaled steroid therapy in children with asthma that evaluated linear growth.

Study Selection.  Studies were included if they met the following criteria: subjects 0 to 18 years of age with the clinical diagnosis of asthma; subjects randomized to inhaled beclomethasone, budesonide, flunisolide, fluticasone, or triamcinolone versus a nonsteroidal inhaled control for a minimum of 3 months; single- or double-blind; and outcome convertible to linear growth velocity. English- and non-English-language trials were included.

Data Extraction.  Data were extracted using a priori guidelines. Methodologic quality was assessed independently by both authors. Outcome was extracted as linear growth velocity.

Results.  Included trials were subgrouped by inhaled steroid. The beclomethasone subgroup, with 4 studies and 450 subjects, showed a decrease in linear growth velocity of 1.51 cm/year (95% confidence interval: 1.15,1.87). The fluticasone subgroup, with 1 study and 183 subjects, showed a decrease in linear growth velocity of .43 cm/year (95% confidence interval: .01,.85). Sensitivity analysis in the beclomethasone subgroup, which evaluated study quality, mode of medication delivery, control medication, and statistical model, showed similar results.

Conclusions.  This meta-analysis suggests that moderate doses of beclomethasone and fluticasone in children with mild to moderate asthma cause a decrease in linear growth velocity of 1.51 cm/year and .43 cm/year, respectively. The effects of inhaled steroids when given for >54 weeks, or on final adult height, remain unknown.  Key words:  asthma, children, growth, inhaled steroid, beclomethasone, fluticasone.




This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
B. Coureau, J.-F. Bussieres, and S. Tremblay
Cushing's Syndrome Induced by Misuse of Moderate- to High-Potency Topical Corticosteroids
Ann. Pharmacother., December 1, 2008; 42(12): 1903 - 1907.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
I. M. Balfour-Lynn, B. Lees, P. Hall, G. Phillips, M. Khan, M. Flather, J. S. Elborn, and on behalf of the CF WISE (Withdrawal of Inhaled St
Multicenter Randomized Controlled Trial of Withdrawal of Inhaled Corticosteroids in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1356 - 1362.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
N. S. Eid
Update on National Asthma Education and Prevention Program Pediatric Asthma Treatment Recommendations
Clinical Pediatrics, November 1, 2004; 43(9): 793 - 802.
[Abstract] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
S. V. Bourdet and D. Williams
Management Considerations for Chronic Asthma
Journal of Pharmacy Practice, April 1, 2001; 14(2): 108 - 125.
[Abstract] [PDF]

Home page
 Eur Respir JHome page
P.L.P. Brand
Inhaled corticosteroids reduce growth. Or do they?
Eur. Respir. J., February 1, 2001; 17(2): 287 - 294.
[Abstract] [Full Text] [PDF]